Family History and Gastric Cancer Risk: A Pooled Investigation in the Stomach Cancer Pooling (STOP) Project Consortium.
family history
gastric cancer
international consortium
meta-analyses
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
30 Jul 2021
30 Jul 2021
Historique:
received:
21
06
2021
revised:
14
07
2021
accepted:
15
07
2021
entrez:
7
8
2021
pubmed:
8
8
2021
medline:
8
8
2021
Statut:
epublish
Résumé
Although there is a clear relationship between family history (FH) and the risk of gastric cancer (GC), quantification is still needed in relation to different histological types and anatomical sites, and in strata of covariates. The objective was to analyze the risk of GC according to first-degree FH in a uniquely large epidemiological consortium of GC. This investigation includes 5946 cases and 12,776 controls from 17 studies of the Stomach Cancer Pooling (StoP) Project consortium. Summary odds ratios (OR) and the corresponding 95% confidence intervals (CIs) were calculated by pooling study-specific ORs using fixed-effect model meta-analysis techniques. Stratified analyses were carried out by sex, age, tumor location and histological type, smoking habit, socioeconomic status, alcohol intake and fruit consumption. The pooled OR for GC was 1.84 (95% CI: 1.64-2.04; I2 = 6.1%, P heterogeneity = 0.383) in subjects with vs. those without first-degree relatives with GC. No significant differences were observed among subgroups of sex, age, geographic area or study period. Associations tended to be stronger for non-cardia (OR = 1.82; 95% CI: 1.59-2.05 for subjects with FH) than for cardia GC (OR = 1.38; 95% CI: 0.98-1.77), and for the intestinal (OR = 1.92; 95% CI: 1.62-2.23) than for the diffuse histotype (OR = 1.62; 95% CI: 1.28-1.96). This analysis confirms the effect of FH on the risk of GC, reporting an approximately doubled risk, and provides further quantification of the risk of GC according to the subsite and histotype. Considering these findings, accounting for the presence of FH to carry out correct prevention and diagnosis measures is of the utmost importance.
Identifiants
pubmed: 34359744
pii: cancers13153844
doi: 10.3390/cancers13153844
pmc: PMC8345354
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Jpn J Clin Oncol. 2002 Aug;32(8):284-90
pubmed: 12411565
Carcinogenesis. 1999 Dec;20(12):2195-208
pubmed: 10590210
Cancer Causes Control. 2004 Feb;15(1):67-72
pubmed: 14970736
Jpn J Clin Oncol. 2002 Aug;32(8):277-83
pubmed: 12411564
Am J Epidemiol. 2006 Jun 1;163(11):1053-64
pubmed: 16624970
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):73-80
pubmed: 10667466
Gastroenterology. 2001 Dec;121(6):1286-93
pubmed: 11729107
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Int J Cancer. 2002 Feb 10;97(5):688-94
pubmed: 11807799
Occup Environ Med. 2012 Apr;69(4):268-75
pubmed: 22068174
Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):15-8
pubmed: 8118379
Gastroenterol Res Pract. 2020 Oct 22;2020:4028136
pubmed: 33144855
Eur J Cancer Prev. 2007 Aug;16(4):312-27
pubmed: 17554204
Gastric Cancer. 2018 Sep;21(5):729-737
pubmed: 29455268
Int J Cancer. 1995 Mar 16;60(6):748-52
pubmed: 7896439
Cancer Causes Control. 2011 May;22(5):725-36
pubmed: 21347819
Biomed Res Int. 2013;2013:385132
pubmed: 23484115
Int J Cancer. 2005 Oct 10;116(6):972-83
pubmed: 15856451
Br J Cancer. 2010 Jan 19;102(2):237-42
pubmed: 19888225
Gastric Cancer. 2004;7(1):46-53
pubmed: 15052440
N Engl J Med. 2000 Jul 13;343(2):78-85
pubmed: 10891514
Eur J Cancer Prev. 2003 Jun;12(3):183-9
pubmed: 12771555
Korean J Intern Med. 2016 Nov;31(6):1042-1053
pubmed: 27809451
Eur J Cancer. 2009 Nov;45(16):2867-73
pubmed: 19427197
Jpn J Cancer Res. 2001 Aug;92(8):829-35
pubmed: 11509113
Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1395-408
pubmed: 23697611
Int J Cancer. 2003 Nov 20;107(4):629-34
pubmed: 14520702
Gastroenterol Clin North Am. 2013 Jun;42(2):219-40
pubmed: 23639638
Eur J Cancer Prev. 2000 Dec;9(6):401-8
pubmed: 11201678
Int J Cancer. 2009 Oct 15;125(8):1953-60
pubmed: 19569234
Lancet Gastroenterol Hepatol. 2018 Dec;3(12):874-883
pubmed: 30507471
Asian Pac J Cancer Prev. 2018 Mar 27;19(3):591-603
pubmed: 29579788
Clin Epidemiol. 2018 Sep 04;10:1169-1179
pubmed: 30233251
Cancer Causes Control. 2009 Apr;20(3):361-8
pubmed: 18989634
Int J Cancer. 1999 Aug 12;82(4):473-6
pubmed: 10404057
Eur J Cancer Prev. 2015 Jan;24(1):16-23
pubmed: 24566154
Gac Sanit. 2015 Jul-Aug;29(4):308-15
pubmed: 25613680
BMC Cancer. 2012 Oct 25;12:494
pubmed: 23098561
BMC Cancer. 2009 Sep 28;9:346
pubmed: 19785726
Int J Cancer. 2008 Sep 15;123(6):1429-32
pubmed: 18567000
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120